Litigation Details for Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. (D. Del. 2018)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-07-16 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Defendant | Referred To | |
| Patents | 9,187,405 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-06-05 | 561 | Opinion - Memorandum Opinion | of U.S . Patent No. 9,187,405 ("the '405 patent"). (D.I. 1) The '405 patent "relates…the '405 patent, as well as the meaning of the term "daily dosage." The Patent Trial and …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent "specification…disease, e.g. multiple sclerosis." (' 405 patent at Abstract) The parties dispute the significance | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
